Related Experiment Video
Updated: Aug 5, 2026
08:54
Development of a Multicellular Three-dimensional Organotypic Model of the Human Intestinal Mucosa Grown Under Microgravity
Published on: July 25, 2016
[Insulin-like growth factor 1 in patients with multiple organ dysfunction during hemofiltration/hemodiafiltration]
Anesteziologiia I Reanimatologiia
|June 9, 2005
Summary
Patients with multiple organ dysfunction experience low insulin-like growth factor 1 (IGF-1) levels. Renal replacement therapy (RRT) further reduces IGF-1, suggesting early supplementation is crucial for metabolic adaptation.
Area of Science:
- Biochemistry
- Endocrinology
- Nephrology
Context:
- Severe diseases cause neurohumoral stress and catabolism.
- Insulin and IGF-1 regulate metabolism, but RRT may eliminate significant IGF-1 amounts.
- This study investigates IGF-1 levels in patients with multiple organ dysfunction undergoing RRT.
Purpose:
- To determine IGF-1 levels in patients with multiple organ dysfunction during hemofiltration/hemodiafiltration (HF/HDF).
- To assess the elimination of IGF-1 during RRT.
- To evaluate the impact of RRT on IGF-1 levels and metabolic adaptation.
Summary:
- Patients with multiple organ dysfunction exhibited significantly low IGF-1 levels before and during RRT.
- High elimination of IGF-1 was observed during HF/HDF, with clearance comparable to pro-inflammatory cytokines.
- IGF-1 clearance during RRT was similar to that of TNF-alpha and IL-1beta.
Impact:
- Findings suggest that IGF-1 is significantly eliminated during RRT in critically ill patients.
- Early IGF-1 replacement therapy is recommended for patients with multiple organ dysfunction to manage hypercatabolism.
- This research highlights the importance of considering hormone replacement in patients undergoing RRT for critical illnesses.
Related Concept Videos
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:27Dialysis
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:25Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...